COMBINATION TREATMENT FOR CANCER INVOLVING ANTI-ICOS AND ANTI-PD1 ANTIBODIES, OPTIONALLY FURTHER INVOLVING ANTI-TIM3 ANTIBODIES
Publication
EP4136113A1
Kind: A1
Mar 18, 2026
Applicants
GlaxoSmithKline Intellectual Property Development Limited
Inventors
BALLAS, Marc S., ELLIS, Catherine E., HIRSCHFELD, Steven
IPC Classifications
C07K 16/28 20060101AFI20211022BHEP
A61K 39/395 20060101ALI20211022BHEP
A61P 35/00 20060101ALI20211022BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR